Menu
Curie Logo
Faire un don
  • Accueil >
  • Publications >
  • Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA

Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA

1 août 2015The Breast

DOI : 10.1016/j.breast.2015.02.035

Auteurs

J.-P. Spano, P. Beuzeboc, D. Coeffic, L. Arnould, A. Lortholary, F. Andre, J.-M. Ferrero